4.6 Article

A New Preoperative Scoring System for Predicting Aggressiveness of Non-Functioning Pancreatic Neuroendocrine Neoplasms

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Utility of contrast-enhanced harmonic endoscopic ultrasonography for predicting the prognosis of pancreatic neuroendocrine neoplasms

Rei Ishikawa et al.

Summary: This study suggests that contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) is valuable for predicting the prognosis of Pancreatic neuroendocrine neoplasms (PanNENs), especially in diagnosing aggressive cases. Hypo-enhancement on CH-EUS may indicate a poorer prognosis for G1/G2 PanNENs.

DIGESTIVE ENDOSCOPY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

18F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up Study

Tina Binderup et al.

Summary: This study demonstrated the long-term prognostic value of F-18-FDG PET imaging for risk stratification of neuroendocrine neoplasms, surpassing tumor grading. F-18-FDG PET is able to differentiate low- and high-risk groups even within G1 and G2 tumors, providing valuable information for treatment selection and risk assessment in NEN patients.

JOURNAL OF NUCLEAR MEDICINE (2021)

Article Gastroenterology & Hepatology

Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors

Stefano Francesco Crino et al.

Summary: This study compared EUS-FNA and EUS-FNB in evaluating pNETs, finding that EUS-FNB outperformed EUS-FNA in assessing small pNETs and had a stronger correlation with Ki-67 values from surgical specimens.

PANCREATOLOGY (2021)

Article Gastroenterology & Hepatology

Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: A multicenter nationwide study

Woo Hyun Paik et al.

Summary: This study investigated the clinical course and risk factors for malignant potential of small PNENs, finding that WHO grade is responsible for the malignant potential of small PNENs <= 2 cm. Therefore, EUS-FNAB could be recommended for early treatment strategies.

PANCREATOLOGY (2021)

Review Medicine, General & Internal

Role of Endoscopic Ultrasound in the Diagnosis of Pancreatic Neuroendocrine Neoplasms

Tatsuya Ishii et al.

Summary: Advancements in diagnostic imaging technologies like endoscopic ultrasound and fine-needle aspiration have improved the detection and evaluation of pancreatic neuroendocrine neoplasms. Studies have shown high concordance rates in malignancy detection and pathological grading with these techniques. Further developments in ultrasound imaging technologies, artificial intelligence, needle technology, and genetic analysis are expected to enhance the diagnosis and treatment of PNENs in the future.

DIAGNOSTICS (2021)

Article Oncology

Trends in Incidence and Survival of Patients with Pancreatic Neuroendocrine Neoplasm, 1987-2016

Jingxuan Wang et al.

Summary: With advancements in medical care, the incidence and survival duration of pNEN have increased every decade. Disparities in long-term survival among different age, sex, and grade groups have widened over time, while those in race and SES groups have narrowed. Older age and higher grade are independent risk factors for poorer survival.

JOURNAL OF ONCOLOGY (2021)

Article Gastroenterology & Hepatology

A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors

Wen-Quan Wang et al.

Summary: This study identified a novel risk factor panel, including PanNET G3 grade, pancreatic duct dilatation, and perineural invasion, which predicted early recurrence of PanNETs after curative resection. Patients with these risk factors can benefit from adjuvant therapy with long-acting somatostatin analogs (SSAs).

JOURNAL OF GASTROENTEROLOGY (2021)

Article Medicine, General & Internal

Incidence, Clinical Presentation and Trends in Indication for Diagnostic Work-Up of Small Intestinal and Pancreatic Neuroendocrine Tumors

Anna Bryan Stensbol et al.

Summary: The incidence of siNET and pNETs has increased over the past decade. There has been an increase in incidentally discovered pNET cases, and 44% of incidentally discovered siNET patients had disseminated disease.

DIAGNOSTICS (2021)

Review Oncology

Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?

Satya Das et al.

Summary: The purpose of the review is to explore global epidemiologic trends of gastroenteropancreatic neuroendocrine tumors (NETs), looking at differences in incidence, prevalence, distribution, and overall survival between different regions. GEP NET incidence rates are rising steadily in North America, Asia, and Europe, with differences in distribution of NETs among regions. Improved overall survival for GEP NET patients is also observed over time.

CURRENT ONCOLOGY REPORTS (2021)

Article Endocrinology & Metabolism

Reconsideration of Clinicopathologic Prognostic Factors in Pancreatic Neuroendocrine Tumors for Better Determination of Adverse Prognosis

Anil Aysal et al.

Summary: The study investigated the impact of clinicopathological features on the prognosis of pancreatic neuroendocrine tumors (panNET) and found associations between factors such as vascular invasion, tumor size, mitotic count, and Ki67 proliferation index with prognosis. By comparing different thresholds for predictive indicators, better stratification of panNET patients with poor prognosis can be achieved.

ENDOCRINE PATHOLOGY (2021)

Article Gastroenterology & Hepatology

A simple prediction score for in-hospital mortality in patients with nonvariceal upper gastrointestinal bleeding

Tamotsu Matsuhashi et al.

Summary: A novel prediction score (CHAMPS-R Score) for in-hospital mortality in nonvariceal UGIB patients was successfully derived and externally validated, showing high discriminative ability in both derivation and validation cohorts. The CHAMPS Score outperformed existing scores such as the Glasgow Blatchford Score, AIMS65, ABC Score, and clinical Rockall Score in predicting mortality.

JOURNAL OF GASTROENTEROLOGY (2021)

Article Medicine, General & Internal

Nomogram for predicting survival of patients with metastatic nonfunctioning pancreatic neuroendocrine tumors A SEER based study

Lina Ge et al.

Summary: This study established a nomogram model for patients with metastatic nonfunctioning pancreatic neuroendocrine tumors (NFpNETs), which can help clinicians identify high-risk patients and more accurately assess patient survival times.

MEDICINE (2021)

Article Gastroenterology & Hepatology

Management of Small Nonfunctioning Pancreatic Neuroendocrine Tumors

Shunrong Ji et al.

PANCREAS (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma

Grigory Karmazanovsky et al.

EUROPEAN JOURNAL OF RADIOLOGY (2019)

Article Gastroenterology & Hepatology

Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors

Alexander V. Fisher et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis

Rodrigo Canellas et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2018)

Article Oncology

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67

C. G. Genc et al.

ANNALS OF SURGICAL ONCOLOGY (2018)

Article Multidisciplinary Sciences

A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms

Yong Gao et al.

SCIENTIFIC REPORTS (2018)

Article Endocrinology & Metabolism

Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours

Logan Mills et al.

ENDOCRINE CONNECTIONS (2017)

Article Gastroenterology & Hepatology

A Scoring System to Stratify Curability after Endoscopic Submucosal Dissection for Early Gastric Cancer: eCura system

Waku Hatta et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Article Health Care Sciences & Services

Regression coefficient-based scoring system should be used to assign weights to the risk index

Hemalkumar B. Mehta et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)

Article Gastroenterology & Hepatology

Surgical Resection Provides an Overall Survival Benefit for Patients with Small Pancreatic Neuroendocrine Tumors

Susan M. Sharpe et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2015)

Article Oncology

Population-Level Analysis of Pancreatic Neuroendocrine Tumors 2 cm or Less in Size

Eric J. Kuo et al.

ANNALS OF SURGICAL ONCOLOGY (2013)

Article Endocrinology & Metabolism

Observational Study of Natural History of Small Sporadic Nonfunctioning Pancreatic Neuroendocrine Tumors

Sebastien Gaujoux et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)